Home > Insider Trading > Filing (0001209191-15-065346)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	Pharmaceutical Preparations (2834)	981032470

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1302443	E Rick Winningham	C/O Theravance Biopharma Us, Inc. 901 Gateway Boulevard South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2015-08-07	1,310	$0.00	15,460	No	4	A	Direct
Ordinary Shares	Disposition	2015-08-10	797	$179.98	14,663	No	4	S	Direct
Ordinary Shares	Disposition	2015-08-10	4	$183.36	14,659	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Nonstatutory Stock Option (right to buy)	Acquisiton	2015-08-07	3,415	$0.00	3,415	$181.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,415		2025-08-06	No	4	A	Direct

Footnotes

These restricted stock units are granted pursuant to the Issuer's 2007 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2016.
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
This option is granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vests in 12 equal monthly installments beginning on August 1, 2015.